Renáta H.
- Country
- Slovakia
- Department
- Dermatovenerologicka ambulancia
Research Overview
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Efficacy, Safety, and Pharmacokinetics of Tildrakizumab and Etanercept in Pediatric Patients with Moderate to Severe Chronic Plaque Psoriasis
- A global, multicenter, randomized, double-blind, double-dummy, parallel-group, Phase 3b study to assess the efficacy, safety, and tolerability of remibrutinib 25 mg b.i.d. in comparison to placebo with omalizumab 300 mg every 4 weeks as active control over 52 weeks in adult patients with chronic spontaneous urticaria inadequately controlled by second-generation H1-antihistamines and an open-label 52-week optional extension to assess long-term efficacy, safety and tolerability of remibrutinib 25 mg b.i.d.
Data & Insights
Has run more than one trial at 159 of 357 partner sites.
Specializations
Atopic Dermatitis
Renáta Hodábová is involved in clinical research focused on moderate to severe atopic dermatitis, with attention to therapies that target persistent inflammatory skin disease and improve disease control in routine dermatology practice.
- Atopic dermatitis symptom control
- Eczema severity reduction
- Topical anti-inflammatory treatment combinations
Her trial activity reflects interest in treatment options that address visible skin involvement, pruritus, and long-term disease worsening in patients requiring advanced dermatologic care.
Chronic Spontaneous Urticaria
Her research landscape includes chronic spontaneous urticaria, with involvement in studies evaluating novel immune-directed therapies for patients with ongoing wheals, itch, and inadequate response to standard antihistamine-based management.
- Urticaria activity reduction
- Pruritus and hive burden
- Immune-mediated urticaria treatment
This area of work is centered on symptom relief and sustained control of recurrent urticarial disease in adult dermatology care.
Pediatric Psoriasis
She is also engaged in clinical trials for moderate to severe chronic plaque psoriasis in pediatric subjects, supporting research into systemic options for children and adolescents living with extensive inflammatory skin disease.
- Pediatric plaque psoriasis
- Skin clearance outcomes
- Long-term psoriasis management
Her involvement highlights therapeutic interest in age-specific dermatologic care and in approaches designed for sustained disease improvement in younger patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.